PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 5, 2023Environment International182 citationsOpen Access

Towards monitoring of antimicrobial resistance in the environment: For what reasons, how to implement it, and what are the data needs?

JBJohan Bengtsson‐PalmeAAAnna AbramovaTBThomas U. Berendonk

Key Points

Key points are not available for this paper at this time.

Abstract

Antimicrobial resistance (AMR) is a global threat to human and animal health and well-being. To understand AMR dynamics, it is important to monitor resistant bacteria and resistance genes in all relevant settings. However, while monitoring of AMR has been implemented in clinical and veterinary settings, comprehensive monitoring of AMR in the environment is almost completely lacking. Yet, the environmental dimension of AMR is critical for understanding the dissemination routes and selection of resistant microorganisms, as well as the human health risks related to environmental AMR. Here, we outline important knowledge gaps that impede implementation of environmental AMR monitoring. These include lack of knowledge of the 'normal' background levels of environmental AMR, definition of high-risk environments for transmission, and a poor understanding of the concentrations of antibiotics and other chemical agents that promote resistance selection. Furthermore, there is a lack of methods to detect resistance genes that are not already circulating among pathogens. We conclude that these knowledge gaps need to be addressed before routine monitoring for AMR in the environment can be implemented on a large scale. Yet, AMR monitoring data bridging different sectors is needed in order to fill these knowledge gaps, which means that some level of national, regional and global AMR surveillance in the environment must happen even without all scientific questions answered. With the possibilities opened up by rapidly advancing technologies, it is time to fill these knowledge gaps. Doing so will allow for specific actions against environmental AMR development and spread to pathogens and thereby safeguard the health and wellbeing of humans and animals.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bengtsson‐Palme et al. (2023) studied this question.

synapsesocial.com/papers/6a404906a307ad3478fd7bd2https://doi.org/10.1016/j.envint.2023.108089
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Carriage of CTX-M type extended spectrum β-lactamases (ESBLs) in gulls across Europe2015 · 91 citations
  2. 2Clinical relevance of the ESKAPE pathogens2013 · 1,467 citations
  3. 3LUCAS Soil, the largest expandable soil dataset for Europe: a review2017 · 706 citations
  4. 4Shotgun metagenomics reveals a wide array of antibiotic resistance genes and mobile elements in a polluted lake in India2014 · 243 citations
  5. 5Existing evidence on antibiotic resistance exposure and transmission to humans from the environment: a systematic map2022 · 117 citations